Overview
What is Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc?
Epilepsy Study Consortium Inc, under the umbrella of Sterling Foundation Management Llc, is a nonprofit organization based in Reston, Virginia. Their primary mission is to expedite the development of novel therapies for epilepsy, aiming to enhance patient care. They achieve this goal through research, providing expert advice for advisory boards and independent consulting activities. The organization has contributed to the design of various protocols and developed educational tools for clinical trials, ensuring the enrollment of suitable subjects. Central review of documentation is also conducted to confirm patient eligibility in these trials. With a workforce of six individuals, Epilepsy Study Consortium Inc is dedicated to improving the lives of those affected by epilepsy.
Official website here: www.epilepsyconsortium.org
Is Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc legitimate?
Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $314,494
Professional Fundraising Fees: $0
Other Salaries and Wages: $279,634
For more financial information, click here
Official website here: www.epilepsyconsortium.org
What is the mission statement of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc?
The Epilepsy Study Consortium Inc., managed by Sterling Foundation Management Llc, is dedicated to accelerating the development of novel therapies for epilepsy with the ultimate goal of enhancing patient care. They utilize their extensive epilepsy expertise in advisory boards and independent consulting activities. The consortium provides study design consultation on various protocols, develops and implements educational tools for clinical trials to ensure appropriate subject enrollment, and central reviews documentation to confirm patient eligibility in clinical trials. In essence, their mission is to facilitate research in epilepsy therapy development, ultimately aiming to improve patient care.
Official website here: www.epilepsyconsortium.org
Who is the CEO of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc?
James Lintott is the Treasurer of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc.
Official website here: www.epilepsyconsortium.org
What is the revenue of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc?
Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc's revenue in 2022 was $2,128,414.
Official website here: www.epilepsyconsortium.org
Who are the executives of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc and what are their salaries?
The average compensation at Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc during 2022 was $99,021. There are 6 employees and 11 volunteers at Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc.
Here are 13 key members and their salaries:
- Bree Diventura (Co-Executive Director)
- Meryl Lozano (Co-Executive Director)
- Michael Sperling Md (Vice President) [Trustee/Director]
- James Lintott Esq (Treasurer) [Trustee/Director]
- Jacqueline French Md (President) [Trustee/Director]
- Dennis Dlugos Md (Vice President) [Trustee/Director]
- Daniel Friedman Md (Director)
- Gregory Krauss Md (Director)
- John Pollard Md (Director)
- Pavel Klein Md (Director)
- Sudha Kessler Md (Director)
- Marc Dichter Md Phd (Director)
- Hina Dave Md (Director)
Official website here: www.epilepsyconsortium.org
Where can I find the form 990 for Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc?
The Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.epilepsyconsortium.org
Learn more at the official website: www.epilepsyconsortium.org
Mission Statement of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc
The Epilepsy Study Consortium Inc, under the management of Sterling Foundation Management Llc, is committed to expediting the creation of innovative therapies for epilepsy. Their primary objective is to enhance patient care by conducting extensive research in this field. This nonprofit organization offers its extensive epilepsy expertise for advisory boards and independent consulting activities. They have played a significant role in providing consultation on various study designs, contributing to the development and implementation of educational tools for clinical trials. These tools ensure the enrollment of suitable subjects, thereby contributing to the success of these trials. Moreover, Epilepsy Study Consortium Inc conducts central reviews of documentation to confirm the eligibility of patients participating in clinical trials. This meticulous process helps maintain the integrity of these trials and contributes to the development of effective therapies for epilepsy patients.
Impact
This information is meant to be a general summary of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Epilepsy Study Consortium Inc C/O Sterling Foundation Management LLC's impact lies in accelerating the development of new therapies in epilepsy to improve patient care through research. This organization provides consulting services that offer vast epilepsy expertise, advisory boards, study design consultation, and the development of educational tools for clinical trials. By centralizing the review of documentation to confirm patient eligibility for clinical trials, they ensure appropriate subjects are enrolled, ultimately contributing to advancements in epilepsy treatment and care.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONSULTING
Revenue
$1,330,844
HUMAN EPILEPSY PROJECT
Revenue
$175,807
Organization Details
Founding Year
2006
Phone
(703) 437-9720
Principal Officer
James Lintott
Main Address
12030 SUNRISE VALLEY DRIVE 450, RESTON, VA, 20191
Website
www.epilepsyconsortium.org
NTEE Category
Code: G54 - Disease
If you are a representative of Epilepsy Study Consortium Inc C/O Sterling Foundation Management Llc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.